drugset
drugset / Trial / NCT02996760

Influence Instillation Plasma Rich in Growth Factors in Endometrial Cavity Endometrial Development in Assisted Reproduction.

NCT02996760 ↗

Phase 3 Terminated 22 enrolled IVI Bilbao
RandomizedParallel-groupOpen-labelTreatment

Summary

Women in assisted reproduction treatment they receive own or donated embryos and presenting an endometrial development less than 5 mm despite having received treatment with estrogen therapy knowing the clinical value of using the PRGF-Endoret therapy and endometrial level applications to improve endometrial thickness endometrial preparations for embryo transfer.

Timeline

Start
2018-03-14
Primary completion
2021-12-31
Completion
2021-12-31

Outcome

Outcome not reported

Stopped (Enrollment): “difficulty in recruiting”

Drugs

EvaluationDrugModalityDoseRoute
Subject PRGF-Endoret Protein / enzyme biologic 0.5 ml Other

Indications

No indication recorded.